The Paris-based company Biolevate, which develops AI automation for use in regulated life sciences, has raised €30m in its Series A funding and has opened an office in Boston. Orange Ventures and RAISE France co-led the fundraising exercise, with the company stating that RAISE France is the investment arm of Aymar Hénin, a French entrepreneur. […]
This story continues at The Next WebRead More